Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review

Since the beginning of the coronavirus disease 2019 (COVID-19) outbreak, the disease has rapidly become a global threat. The constant emergence of new variants has increased the difficulty of controlling this disease. Vaccination is still considered the most effective method to prevent COVID-19. Vac...

Full description

Bibliographic Details
Main Authors: Shuang Liu, Jiayi Zhong, Dingmei Zhang
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/7/1083
_version_ 1797443277155205120
author Shuang Liu
Jiayi Zhong
Dingmei Zhang
author_facet Shuang Liu
Jiayi Zhong
Dingmei Zhang
author_sort Shuang Liu
collection DOAJ
description Since the beginning of the coronavirus disease 2019 (COVID-19) outbreak, the disease has rapidly become a global threat. The constant emergence of new variants has increased the difficulty of controlling this disease. Vaccination is still considered the most effective method to prevent COVID-19. Vaccination has expanded to include children aged 3–17 years old, and some countries have lowered the age of vaccination to 6 months (for example, the United States). However, children under 3 years old are still not able to be vaccinated in most countries. In this study, we summarize the COVID-19 vaccination status in pregnant women, comprehensively elaborate on the status of maternal immune response and maternal antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination, and further analyze the possible influencing factors of maternal antibody transfer according to the currently available evidence on the topic. It was concluded that pregnant women develop an immune response and produce antibodies that can be transmitted through the placenta after vaccination, but more data are needed to determine the transfer rate and duration of these maternal antibodies and potential factors. The results provide a scientific basis for studying the protective effect of maternal antibodies on infants, formulating a vaccination strategy for pregnant women, and preventing SARS-CoV-2 infection in infants.
first_indexed 2024-03-09T12:53:37Z
format Article
id doaj.art-257979cdabdd4252a8a9cf75b24bbec7
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T12:53:37Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-257979cdabdd4252a8a9cf75b24bbec72023-11-30T22:02:54ZengMDPI AGVaccines2076-393X2022-07-01107108310.3390/vaccines10071083Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A ReviewShuang Liu0Jiayi Zhong1Dingmei Zhang2Department of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, ChinaDepartment of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, ChinaDepartment of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, ChinaSince the beginning of the coronavirus disease 2019 (COVID-19) outbreak, the disease has rapidly become a global threat. The constant emergence of new variants has increased the difficulty of controlling this disease. Vaccination is still considered the most effective method to prevent COVID-19. Vaccination has expanded to include children aged 3–17 years old, and some countries have lowered the age of vaccination to 6 months (for example, the United States). However, children under 3 years old are still not able to be vaccinated in most countries. In this study, we summarize the COVID-19 vaccination status in pregnant women, comprehensively elaborate on the status of maternal immune response and maternal antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination, and further analyze the possible influencing factors of maternal antibody transfer according to the currently available evidence on the topic. It was concluded that pregnant women develop an immune response and produce antibodies that can be transmitted through the placenta after vaccination, but more data are needed to determine the transfer rate and duration of these maternal antibodies and potential factors. The results provide a scientific basis for studying the protective effect of maternal antibodies on infants, formulating a vaccination strategy for pregnant women, and preventing SARS-CoV-2 infection in infants.https://www.mdpi.com/2076-393X/10/7/1083COVID-19 vaccinepregnancymaternal antibodyantibodies transfer
spellingShingle Shuang Liu
Jiayi Zhong
Dingmei Zhang
Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
Vaccines
COVID-19 vaccine
pregnancy
maternal antibody
antibodies transfer
title Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
title_full Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
title_fullStr Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
title_full_unstemmed Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
title_short Transplacental Transfer of Maternal Antibody against SARS-CoV-2 and Its Influencing Factors: A Review
title_sort transplacental transfer of maternal antibody against sars cov 2 and its influencing factors a review
topic COVID-19 vaccine
pregnancy
maternal antibody
antibodies transfer
url https://www.mdpi.com/2076-393X/10/7/1083
work_keys_str_mv AT shuangliu transplacentaltransferofmaternalantibodyagainstsarscov2anditsinfluencingfactorsareview
AT jiayizhong transplacentaltransferofmaternalantibodyagainstsarscov2anditsinfluencingfactorsareview
AT dingmeizhang transplacentaltransferofmaternalantibodyagainstsarscov2anditsinfluencingfactorsareview